219 related articles for article (PubMed ID: 18293166)
21. Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ.
Zhou X; Ringseis R; Wen G; Eder K
Acta Vet Scand; 2014 Apr; 56(1):21. PubMed ID: 24716857
[TBL] [Abstract][Full Text] [Related]
22. The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
Harrington LS; Moreno L; Reed A; Wort SJ; Desvergne B; Garland C; Zhao L; Mitchell JA
PLoS One; 2010 Mar; 5(3):e9526. PubMed ID: 20209098
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
24. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
25. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
[TBL] [Abstract][Full Text] [Related]
27. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
28. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
[TBL] [Abstract][Full Text] [Related]
29. The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.
Galatou E; Kelly T; Lazou A
Mol Cell Biochem; 2014 Oct; 395(1-2):145-54. PubMed ID: 24939361
[TBL] [Abstract][Full Text] [Related]
30. Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production.
Papatheodorou I; Galatou E; Panagiotidis GD; Ravingerová T; Lazou A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203800
[TBL] [Abstract][Full Text] [Related]
31. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
32. PPARβ/δ activation protects against corticosterone-induced ER stress in astrocytes by inhibiting the CpG hypermethylation of microRNA-181a.
Ji J; Zeng XN; Cao LL; Zhang L; Zhao Z; Yang DD; Sun XL
Neuropharmacology; 2017 Feb; 113(Pt A):396-406. PubMed ID: 27789312
[TBL] [Abstract][Full Text] [Related]
33. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
34. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
36. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
[TBL] [Abstract][Full Text] [Related]
37. Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.
Kapoor A; Collino M; Castiglia S; Fantozzi R; Thiemermann C
Shock; 2010 Aug; 34(2):117-24. PubMed ID: 19997057
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
39. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
40. Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
Zhou D; Liang Q; He X; Zhan C
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):531-4. PubMed ID: 18846332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
